BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 19416020)

  • 1. Biopolymer-based growth factor delivery for tissue repair: from natural concepts to engineered systems.
    Uebersax L; Merkle HP; Meinel L
    Tissue Eng Part B Rev; 2009 Sep; 15(3):263-89. PubMed ID: 19416020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward delivery of multiple growth factors in tissue engineering.
    Chen FM; Zhang M; Wu ZF
    Biomaterials; 2010 Aug; 31(24):6279-308. PubMed ID: 20493521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinspired tissue engineering: the great promise of protein delivery technologies.
    Quaglia F
    Int J Pharm; 2008 Dec; 364(2):281-97. PubMed ID: 18538517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naturally derived materials-based cell and drug delivery systems in skin regeneration.
    Huang S; Fu X
    J Control Release; 2010 Mar; 142(2):149-59. PubMed ID: 19850093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrices and scaffolds for drug delivery in vascular tissue engineering.
    Zhang G; Suggs LJ
    Adv Drug Deliv Rev; 2007 May; 59(4-5):360-73. PubMed ID: 17513003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface engineered and drug releasing pre-fabricated scaffolds for tissue engineering.
    Chung HJ; Park TG
    Adv Drug Deliv Rev; 2007 May; 59(4-5):249-62. PubMed ID: 17482310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering.
    Lee SH; Shin H
    Adv Drug Deliv Rev; 2007 May; 59(4-5):339-59. PubMed ID: 17499384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rate-programming of nano-particulate delivery systems for smart bioactive scaffolds in tissue engineering.
    Izadifar M; Haddadi A; Chen X; Kelly ME
    Nanotechnology; 2015 Jan; 26(1):012001. PubMed ID: 25474543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The extracellular matrix in wound healing: a closer look at therapeutics for chronic wounds.
    Agren MS; Werthén M
    Int J Low Extrem Wounds; 2007 Jun; 6(2):82-97. PubMed ID: 17558006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal delivery systems for bone morphogenetic proteins in orthopedic applications should model initial tissue repair structures by using a heparin-incorporated fibrin-fibronectin matrix.
    Han D; Liu W; Ao Q; Wang G
    Med Hypotheses; 2008 Sep; 71(3):374-8. PubMed ID: 18565684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Injectable matrices and scaffolds for drug delivery in tissue engineering.
    Kretlow JD; Klouda L; Mikos AG
    Adv Drug Deliv Rev; 2007 May; 59(4-5):263-73. PubMed ID: 17507111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycosaminoglycans restrained in a fibrin matrix improve ECM remodelling by endothelial cells grown for vascular tissue engineering.
    Divya P; Krishnan LK
    J Tissue Eng Regen Med; 2009 Jul; 3(5):377-88. PubMed ID: 19452443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymer carriers for drug delivery in tissue engineering.
    Sokolsky-Papkov M; Agashi K; Olaye A; Shakesheff K; Domb AJ
    Adv Drug Deliv Rev; 2007 May; 59(4-5):187-206. PubMed ID: 17540473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental tissue regeneration by DDS technology of bio-signaling molecules.
    Kimura Y; Tabata Y
    J Dermatol Sci; 2007 Sep; 47(3):189-99. PubMed ID: 17507205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innovative strategies for tissue engineered skin based on multiple growth factors gene transfection.
    Nie X; Yang MJ; Deng MJ; Chai JS; Jin Y; Liu LC
    Med Hypotheses; 2009 Oct; 73(4):516-8. PubMed ID: 19632057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem cells and growth factors-based delivery approaches for chronic wound repair and regeneration: A promise to heal from within.
    Sharma P; Kumar A; Dey AD; Behl T; Chadha S
    Life Sci; 2021 Mar; 268():118932. PubMed ID: 33400933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue engineering for cutaneous wounds: selecting the proper time and space for growth factors, cells and the extracellular matrix.
    Macri L; Clark RA
    Skin Pharmacol Physiol; 2009; 22(2):83-93. PubMed ID: 19188756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled drug delivery in tissue engineering.
    Biondi M; Ungaro F; Quaglia F; Netti PA
    Adv Drug Deliv Rev; 2008 Jan; 60(2):229-42. PubMed ID: 18031864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrices and scaffolds for protein delivery in tissue engineering.
    Tessmar JK; Göpferich AM
    Adv Drug Deliv Rev; 2007 May; 59(4-5):274-91. PubMed ID: 17544542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceramic composites as matrices and scaffolds for drug delivery in tissue engineering.
    Habraken WJ; Wolke JG; Jansen JA
    Adv Drug Deliv Rev; 2007 May; 59(4-5):234-48. PubMed ID: 17478007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.